Table 1 Patient population
Data | Value |
|---|---|
Age | 70 ± 14 years (29–93) |
Male/Female | 16/24 |
Anticoagulation regimen before placement: | |
None | 3 (7.5) |
Vitamin K antagonists | 3 (7.5) |
Direct oral anticoagulants | 7 (17.5) |
Low-Molecular-Weight Heparins | 27 (67.5) |
Indications for placement: | |
Pulmonary thrombo-embolism with contraindication to anticoagulationa | 30 (75) |
Planned surgery with a high risk of both bleeding and pulmonary thrombo-embolism in patients with an < 90 days DVT / PE conditionb | 10 (25) |
Failure of anticoagulant therapy in thrombo-embolic diseases | 0 |
PE/DVT Risk factors: | |
Major surgery scheduled within next 72 hours | 10 (25) |
Active cancer | 16 (40) |
Acute trauma | 5 (12.5) |
Prolonged immobilization | 31 (77.5) |
Hypertension | 15 (37.5) |
Current smoking | 4 (10) |
Obesity | 9 (22.5) |
Diabetes | 3 (7.5) |
Cardiopathy | 8 (20) |